• Filter by Type

  • Filter by Program

  • Filter by Topics

Federal Procurement of Artificial Intelligence: Perils and Possibilities

Federal Procurement of Artificial Intelligence: Perils and Possibilities

December 1, 2020

By David S. Rubenstein

Toward Fair and Sustainable Capitalism

Toward Fair and Sustainable Capitalism

August 13, 2020

By Leo E. Strine, Jr.

Extending the Consumer Safety Net: How the Consumer Financial Protection Bureau Can Use Its Authority to Protect Vulnerable Consumers

Extending the Consumer Safety Net: How the Consumer Financial Protection Bureau Can Use Its Authority to Protect Vulnerable Consumers

July 1, 2020

By Graham Steele

No More Bailouts

No More Bailouts

June 1, 2020

By Ganesh Sitaraman, Lindsay Owens, Adam J. Levitin

Antitrust-Plus: Evaluating Additional Policies to Tackle Labor Monopsony

Antitrust-Plus: Evaluating Additional Policies to Tackle Labor Monopsony

May 14, 2020

By Suresh Naidu, Eric A. Posner

FedAccounts Would Provide Economic Relief—and Inclusion—in the Short and Long Term

FedAccounts Would Provide Economic Relief—and Inclusion—in the Short and Long Term

April 22, 2020

The Contribution of Shareholder Primacy to the Racial Wealth Gap

The Contribution of Shareholder Primacy to the Racial Wealth Gap

February 5, 2020

By Lenore Palladino

AT A GLANCE: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States

AT A GLANCE: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States

December 5, 2019

The Racial Rules of Corporate Power: How Extractive Corporate Power Harms Black and Brown Communities and How Race-Conscious Solutions Can Create an Inclusive Economy

The Racial Rules of Corporate Power: How Extractive Corporate Power Harms Black and Brown Communities and How Race-Conscious Solutions Can Create an Inclusive Economy

November 25, 2019

By Darrick Hamilton, Madeline Neighly

New Rules for the 21st Century: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States

New Rules for the 21st Century: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States

October 28, 2019

By Steph Sterling, Julie Margetta Morgan